Log in to save to my catalogue

Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in gen...

Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in gen...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1285094026

Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder

About this item

Full title

Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder

Publisher

London: Nature Publishing Group UK

Journal title

The pharmacogenomics journal, 2013-02, Vol.13 (1), p.21-26

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Generalized anxiety disorder (GAD) is a chronic psychiatric disorder with significant morbidity and mortality. Antidepressant drugs are the preferred choice for treatment; however, treatment response is often variable. Several studies in major depression have implicated a role of the serotonin receptor gene (
HTR2A
) in treatment response to...

Alternative Titles

Full title

Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1285094026

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1285094026

Other Identifiers

ISSN

1470-269X

E-ISSN

1473-1150

DOI

10.1038/tpj.2011.47

How to access this item